Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2049
Title: The authors reply
Authors: Ramsey, B. W.
Elborn, J. S.
Wainwright, Claire 
Issue Date: 2015
Source: 373, (18), 2015, p. 1783-1784
Pages: 1783-1784
Journal: New England Journal of Medicine
Abstract: L6067364692015-11-10
2015-11-16
DOI: 10.1056/NEJMc1510466
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L606736469&from=exporthttp://dx.doi.org/10.1056/NEJMc1510466 |
Keywords: CFTR gene;cost effectiveness analysis;cystic fibrosis;disease exacerbation;drug cost;forced expiratory volume;homozygosity;hospital admission;cystic fibrosis transmembrane conductance regulator;letter;lung disease;priority journal;NCT02390219antibiotic agent;human;dornase alfa;ivacaftor plus lumacaftor;pancreas enzyme
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

102
checked on Mar 20, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.